# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Toast, Teva, Vistra, Equinix, Applovin, IFF, Constellation, Emerson, IP, and STERIS were top performers last week. Are they in ...
TD Cowen analyst Michael Elias maintains Equinix (NASDAQ:EQIX) with a Buy and lowers the price target from $862 to $859.
Hindenburg Research on X: "Equinix appears to have gone "all-in" on accounting manipulation. Yesterday, the company...
Wall Street is seeing a day of gains as all major indices traded in the green around noon in New York, driven by a surprising u...
Equinix, Inc. reported Q1 FY24 results with revenues up 6%, adjusted EBITDA up to $992M, and a quarterly dividend of $4.26. Pre...
Trading in U.S. index futures suggests stocks may be off to a lackluster start again on Thursday.